Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Discover practical ways to avoid falling into budget traps through smart checks that reinforce your plan and improve long-term financial health.
27,485 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Import prices surged in February, signaling higher inflation coming import pressures. Markets waver as traders price ...
With the CLARITY Act stalled in the Senate, XRP traders await a potential reset. A clearance could alter liquidity an...
XRP trades in a narrow range as three big headwinds keep gains at bay. Analysts flag Bitcoin correlation, whale selli...
Copper prices sit near multi-month highs in March 2026, and investors are eyeing a Chile-focused ETF as a clean coppe...
As kimball (ke) 2026 earnings unfold, investors care most about revenue growth, margin stability, and cash flow. This...
Bitcoin tops $80,000 again as Canaccord Genuity raises MicroStrategy’s price target to $224, highlighting a move towa...
Choosing between two popular ETFs means weighing tech-driven growth against broad small-cap diversification. This gui...
A new voter poll shows broad demand for federal action to reduce housing costs, with cross‑party support for quick pa...
The Goldman Sachs retirement survey shows a split: many workers feel they’re on track for retirement goals, but a maj...
The Roundhill Memory ETF DRAM has surged in 2026, roughly doubling and delivering a year-to-date gain near 100% as AI...
Alphabet's Google rockets to a fresh 52-week high on AI and Cloud strength, yet investors juggle elevated capital exp...